Then, we used scRNA sequencing to further analyze the immune cellular landscape of HCC in the GSE140228 cohort (Fig. 5P) and unveiled the enhanced expression of CCL2 in CD68 + macrophages (Fig. 5Q). The gene discussed is CD68; the disease is hepatocellular carcinoma.